MOG (35-55) amide Mouse, Rat MEVGWYRSPFSRVVHLYRNGK-amide


Immunoglobulin (Ig) superfamily protein expressed in the central nervous system capable of inducing MS like symptoms in animal models

See full description

Catalogue number crb1000379
Sequence (one letter code) MEVGWYRSPFSRVVHLYRNGK-amide
Sequence (three letter code) H-Met-Glu-Val-Gly-Trp-Tyr-Arg-Ser-Pro-Phe-Ser-Arg-Val-Val-His-Leu-Tyr-Arg-Asn-Gly-Lys-NH2
Research Area Multiple Sclerosis
Purity >95%
Storage -20°C
Molecular Weight 2579.3
Citations S. Sriskantharajah et al. (2014). J Immunol. 192(8): 3518–3529. PMC3979668. K. Cook et al.(2015). Front Microbiol. 6:52. PMC4327743. S. Zandee et al. (2017) Immunology and Cell Biology. 95, 484-490. PMID: 28169287.

Peschl, P., Bradl, M., Höftberger, R., Berger, T. and Reindl, M. (2017). Myelin Oligodendrocyte Glycoprotein: Deciphering a Target in Inflammatory Demyelinating Diseases. Front Immunol, 8. PMID: 28533781

Weber, M., Derfuss, T., Metz, I. and Brück, W. (2018). Defining distinct features of anti-MOG antibody associated central nervous system demyelination. Ther Adv Neurol Disord, 11, 175628641876208. PMID: 29623106.

Peschl, P., Schanda, K., Zeka, B., Given, K., Böhm, D., Ruprecht, K., Saiz, A., Lutterotti, A., Rostásy, K., Höftberger, R., Berger, T., Macklin, W., Lassmann, H., Bradl, M., Bennett, J. and Reindl, M. (2017). Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination. J Neuroinflammation, 14(1). PMID: 29070051

Myelin oligodendrocyte glycoprotein (MOG) is a member of the immunoglobulin (Ig) protein superfamily and is expressed exclusively in the central nervous system (CNS) on the surface of myelin sheaths and oligodendrocyte processes. MOG is expressed at the onset of myelination, and therefore is a potential marker for oligodendrocyte maturation.

MOG contains an extracellular domain, a transmembrane domain, a cytoplasmic loop, a membrane-associated region and a cytoplasmic tail.  MOG may function as a cell surface receptor or cell adhesion molecule.  Fifteen different alternatively spliced isoforms have been detected in humans. These are present either on the cell surface, the endoplasmic reticulum in the endocytic system, or in secreted form.

The secreted form of MOG may trigger autoimmunity if released into the cerebrospinal fluid and periphery. MOG is thought to be a key target for auto-antibodies and cell-mediated immune responses in inflammatory demyelinating diseases such as multiple sclerosis (MS) and is therefore widely studied in this field.

The MOG (35-55) fragment is the most potent auto-antigenic region of MOG, and the most effective at inducing experimental autoimmune/allergic encephalomyelitis (EAE), an animal model that resembles MS. This peptide has an uncharged C-terminal amide

MOG (35-55) amide Mouse, Rat

Cat No. Pack Size Price Qty